Endometrial volume as predictor of malignancy in women with postmenopausal bleeding.

OBJECTIVE: To assess endometrial volume as a predictor of endometrial malignancy in women with postmenopausal bleeding. METHODS: Endometrial volume was measured by virtual organ computer-aided analysis in 170 women with postmenopausal bleeding, and histopathologic results of endometrial biopsies were obtained for all. A group of 100 women without postmenopausal bleeding was used for control. RESULTS: There were 90 cases of benign disease, 53 cases of atypia, and 27 cases of endometrial cancers in the study group. Whereas endometrial thickness was 9.61+/-5.12 mm (range, 5-20 mm) and endometrial volume was 3+/-1.1 mL (range, 1.8-5.4 mL) in women with atypia or cancer, they were 4.87+/-3.43 mm (range, 2-8 mm) and 1.52+/-0.82 (range, 0.6-2.2 mL), respectively, in women with benign disease. In the control group, endometrial volume was 1.15+/-0.14 mL (range, 0.6-1.3 mL). Volume was more sensitive than thickness for predicting malignancy, and a cutoff value of 1.35 mL was found to provide the best sensitivity. CONCLUSION: An endometrial volume of 1.35 mL or greater may predict malignancy in women with postmenopausal bleeding.

The immunogenic effect of purified antigens of B. alexandrina against S. mansoni in experimental animals (II) as measured by the histopathological changes in the liver.

It can be safely said that up till now, no method of vaccination (including recent genes encoding vaccines) has yet proved to be totally effective since they gave partial and low levels of protection against S. mansoni infection. The objective of this work is to try testing the immunogenic effect of two purified non infected B. alexandrina hepatopancreas through histopathological changes in liver of Swiss albino mice (15-20 gm). Gel filtration chromatography was used to fractionate the crude antigen into five fractions followed by re-fractionation and determination of their molecular weights by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). Four dilutions of Fiv (20000-29000 daltons) and Fv (20000-24000 daltons) were injected in two groups of mice (33 each) at weekly intervals and another control group was injected with phosphate buffer saline (PBS) in the same manner. Sacrification was done seven weeks from infection with 100 S. mansoni cercariae through immersion method. The results revealed that there is marked histopathological changes in liver of the control group in comparison to the two vaccinated groups which appear more or less normal with slight inflammatory infiltrate.

Development of Wuchereria bancrofti in Culex pipiens L. (Diptera: Culicidae) exposed in the larval instar to sublethal dosages of insecticides and one insect growth regulator and their influence on reproduction of filaria-infected mosquitoes.

The effects of exposure of Culex pipiens larvae to sublethel concentrations of larvicides on uptake, development of Wuchereria bancrofti, survival rate and reproduction of filaria-infected mosquitoes were investigated. Fourth instar larvae of Cx. pipiens were exposed to LC40 of the surfactant Triton X-100, the insect growth regulator DPX alone or combined with LC10 of the surfactant and permethrin alone or combined with LC10 of the surfactant. Adults that survived insecticide treatments and controls were infected by allowing them to feed on microfilaremic volunteers. Significant reduction in the uptake of microfilaria was observed in groups treated with Triton X-100 alone or combined either with permethrin or DPX when compared to control. The overall infection and infective rates were significantly reduced in mosquitoes treated with Triton X-100 either alone or combined with permethrin. Treatment with Triton X-100 and DPX prolonged the extrinsic incubation period (EIP) and retarded the development of filarial larvae, while permethrin either alone or combined with Triton X-100 and DPX combined with Triton X-100 shortened the EIP. All larvicides reduced the number of infective larvae (L3)/mosquito and induced deformities among he different parasite stages, especially in mosquitoes treated with combination of permethrin and Triton X-100 or mixture of DPX and Triton X-100 where 36% and 54.9% respectively of L3S were deformed. In treated mosquitoes, a low percentage of L3S was detected in the head and proboscis region while the majority was trapped in the thoracic region. The survival rates of mosquitoes were reduced in cases treated with permethrin, DPX and Triton X-100 while treatment with mixture of DPX and Triton X-100 induced higher rate of mortalities when compared to control. Egg production of filaria- infected Cx. pipiens was significantly reduced in mosquitoes treated with DPX and Triton X-100. It was observed that the addition of Triton X-100 to DPX or to permethrin significantly reduced egg production. The results suggest that sublethal concentrations of larvicides especially Triton X-100 applied to 4th instar larvae of Cx. pipiens could effectively interfere with the development of W. bancrofti in Cx. pipiens and reduced the survival rate and fecundity of the vector.

Prolactin imbalance as a result of bilharzial hepatosplenomegaly.

Prolactin is an important hormone for maintenance of normal sexual life in human. Prolactin is produced in the lactotropic cells in the lateral wing of the anterior pituitary gland. Prolactin imbalance associated with bilharzial hepatosplenomegaly with subsequent infertility was carried out on sixty female patients and 30 normal controls. In bilharzial patients and 30 normal controls. In bilharzial patients with hepatosplenomegaly, there was hyperprolactinaemia in 13.33% of cases. 10% of patients suffering from bilharzial hepatosplenomegaly had primary infertility and 70% had secondary infertility more than 5 years. Galactorrhea was present in 10% of cases with bilharzial hepatosplenomegaly. There was irreversible relationship between the duration of bilharzial infection and serum prolactin level and inability to conceive, and also between the duration of bilharzial infection and endocrine manifestations as infrequency and irregularity of menstruation.